Pfizer closes Kent plant
Pfizer is planning to close its research and development plan in Kent as part of a plan to trim research spending from over $8bn to less than $7bn. They plan to focus on areas that offer the greatest promise such as cancer and vaccines.
BMJ 2011 342, d771